A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD

Clinical trial NCT04691154 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04691154
Sponsor: Liquidia Technologies, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension Pulmonary Hypertension Due to Lung Diseases

Start date: 2021-08-01
Primary completion: 2025-03-20
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.